May 23, 2016 Sophia Vida
Biotech & PharmaLife

FitBit (NYSE: FIT) Tracker Deemed Highly Innaccurate According To Studies

Fitbit’s class action lawsuit may have just become more complicated as the company’s heart rate accuracy is now in question. A new study, commissioned by Lieff Cabraser, the law firm behind the class action suit, has revealed that the company’s PurePulse heart rate monitor is probably wrong about your heart rate. Researchers at the California … Continue reading “FitBit (NYSE: FIT) Tracker Deemed Highly Innaccurate According To Studies”